Get started
Author

Elke Maria Erne

Observed names: E Erne, E. Erne, E.M. Erne, Elke Erne, Elke M. Erne, Erne, Elke M.
Observed institutions: University of Modena and Reggio Emilia, University of Padua, Universität Ulm, Paracelsus Medical University, German Red Cross, Ospedale di Bolzano, Italian Medicines Agency, Azienda Ospedale - Università Padova, Azienda Sanitaria dell'Alto Adige
ORCID: 0000-0002-9295-7998
Observed ORCID: 0000-0002-9295-7998
OpenAlex ID: A5087701095
Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial
2020 · Francesco Perrone, Maria Carmela Piccirillo, et al. · Journal of Translational Medicine · 144
PDF
Severe Hepatic Failure Related to Nevirapine Treatment
1999 · Anna Maria Cattelan, Elke Erne, et al. · Clinical Infectious Diseases · 71
Population Pharmacokinetic and Pharmacodynamic Analysis of Dalbavancin for Long-Term Treatment of Subacute and/or Chronic Infectious Diseases: The Major Role of Therapeutic Drug Monitoring
2022 · Pier Giorgio Cojutti, Sara Tedeschi, et al. · Antibiotics · 57
PDF
Autoantibodies neutralizing type I IFNs underlie severe tick-borne encephalitis in ∼10% of patients
2024 · Adrian Gervais, Astrid Marchal, et al. · The Journal of Experimental Medicine · 55
PDF
Forecasting Hepatitis C liver disease burden on real‐life data. Does the hidden iceberg matter to reach the elimination goals?
2018 · Loreta A. Kondili, Sarah Robbins, et al. · Liver International · 44
Modeling cost‐effectiveness and health gains of a “universal” versus “prioritized” hepatitis C virus treatment policy in a real‐life cohort
2017 · Loreta A. Kondili, Federica Romano, et al. · Hepatology · 32
PDF
Collection of allogeneic peripheral blood progenitor cells by two protocols on an apheresis system
1998 · T. Schreiner, M. Wiesneth, et al. · Transfusion · 32
In Chronic Hepatitis C Infection, Myeloid-Derived Suppressor Cell Accumulation and T Cell Dysfunctions Revert Partially and Late After Successful Direct-Acting Antiviral Treatment
2019 · Valentina Telatin, Francesco Nicoli, et al. · Frontiers in Cellular and Infection Microbiology · 28
PDF
Genotype-specific mutations in the polymerase gene of hepatitis B virus potentially associated with resistance to oral antiviral therapy
2012 · Silvia Mirandola, Giada Sebastiani, et al. · Antiviral Research · 27
Real-life comparison of mortality in patients with SARS-CoV-2 infection at risk for clinical progression treated with molnupiravir or nirmatrelvir plus ritonavir during the Omicron era in Italy: a nationwide, cohort study
2023 · Carlo Torti, Pier Paolo Olimpieri, et al. · The Lancet Regional Health - Europe · 19
Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS): a prospective observational study
2017 · Salvatore Petta, Marco Marzioni, et al. · The Lancet. Gastroenterology & hepatology · 19
PDF
Highly effective CD34+ selection of granulocyte colony-stimulating factor-mobilized allogeneic peripheral blood progenitor cells [letter]
1996 · T Schreiner, B Maccari, et al. · Blood · 13
PDF
A multicentre real-life prospective cohort study on effectiveness, durability and safety of long-acting injectable cabotegravir and rilpivirine in northern Italy: the LONGITUDE study
2025 · Maria Mazzitelli, Claudia Cozzolino, et al. · Journal of Antimicrobial Chemotherapy · 9
PDF
Safety and efficacy of ombitasvir/paritaprevir/ritonavir/dasabuvir plus ribavirin in patients over 65 years with HCV genotype 1 cirrhosis
2018 · Antonio Ascione, Massimo De Luca, et al. · Infection · 8
PDF
Comparison of T-Cell-Depleted BMT and PBPCT with Respect to Chimerism, Graft Rejection, and Leukemic Relapse
1999 · Markus Wiesneth, Thomas Schreiner, et al. · Journal of Hematotherapy · 8
Chimerism analysis after allogeneic bone marrow transplantation with nonradioactive RFLP and PCR-AFLP using the same DNA
1996 · Thomas Schreiner, Heike Prochnow-Calzia, et al. · Journal of Immunological Methods · 6
Risk of clinical events in virologically suppressed people with HIV switching to a two-drug regimen vs. remaining on a three-drug regimen: a target trial emulation
2025 · Cristina Mussini, Andrea Giacomelli, et al. · EClinicalMedicine · 4
PDF
Dermatological Presentation of Strongyloides stercoralis Infection in Two Elderly Italian Inpatients
2024 · Giulia Gardini, Guenter Froeschl, et al. · Pathogens · 4
Psychiatric Disorders after Switching to Dolutegravir: A Case Report of a 59-Year-Old Virosuppressed HIV-1 Positive Woman
2020 · Daniele Mengato, Raffaella Binazzi, et al. · Case Reports in Infectious Diseases · 4
PDF
Smaller decreases in bone mineral density in chronic hepatitis B patients receiving tenofovir alafenamide compared with tenofovir disoproxil fumarate over 96 weeks
2017 · S. Fung, W.L. Chuang, et al. · Journal of Hepatology · 4
Gender Differences in HCV Chronic Liver Disease: A Real Life Evaluation in Piter (Piattaforma Italiana per Lo Studio Della Terapia Delle Epatiti Virali) Cohort Study
2016 · L. Kondili, M.G. Quaranta, et al. · Journal of Hepatology · 4
Improved lectin agglutination method for T-cell depletion of HLA-mismatched bone marrow grafts in children
1996 · Thomas Schreiner, Markus Wiesneth, et al. · Transfusion Science · 3
HCV-related mixed cryoglobulinemia: Data from PITER, a nationwide Italian HCV cohort study
2016 · L.E. Weimer, M. Vinci, et al. · Digestive and Liver Disease · 2
High efficiency of CD34+ selection by removal of platelets from the apheresis product.
1997 · T Schreiner, B Maccari, et al. · PubMed · 2
Correction to: Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial
2021 · Francesco Perrone, Maria Carmela Piccirillo, et al. · Journal of Translational Medicine · 1
PDF
Works count: 42
Citation count: 601
H-index: 12
I10-index: 12
Year
Topic
Type